ClinicalTrials.govpublic full text
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
multiple sclerosis, mesenchymal stem cells, neural progenitors, autologous, bone marrow, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992627
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.